PAT has aided formulation, both pre-and post-filing, by reducing costs and time frames.
PAT has aided formulation, both pre-and post-filing, by reducing costs and time frames. Contrary to popular beliefs, it doesn’t require big investments.
Download
Pharmaceutical Technology’s 2015 Solid Dosage and Excipients eBook.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.